Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

948 studies match

clinicaltrialsPublishedShowing 651–700 of 948 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01039376	Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy(PROLONG)	terminated	Phase 3	480	Novartis PharmaceuticalsINDUSTRY	25	Jul 30, 2019	clinicaltrials
NCT01646125	An Open-label, Randomized Phase II Study to Evaluate the Efficacy of AUY922 vs Pemetrexed or Docetaxel in NSCLC Patients With EGFR Mutations	terminated	Phase 2	59	Novartis PharmaceuticalsINDUSTRY	12	Jul 24, 2019